Literature DB >> 25524601

Diminished nitric oxide generation from neutrophils suppresses platelet activation in chronic renal failure.

Daniele C Abrantes1, Tatiana M C Brunini, Cristiane Matsuura, Wanda Vianna Mury, Carolina R Corrêa, Sérgio F Santos, Monique B O Ormonde do Carmo, Antônio Cláudio Mendes-Ribeiro.   

Abstract

Chronic renal failure (CRF) is a complex clinical condition associated with accelerated atherosclerosis and thrombosis leading to cardiovascular events. The aim of this study was to investigate in detail the NO pathway in neutrophils obtained from hemodialysis patients and its association with platelet function and oxidative status. Fifteen CRF patients on hemodialysis and fifteen controls were included in this study. Laboratory and experimental evaluations were performed after hemodialysis in CRF patients. We evaluated L-[³H] arginine transport, NO synthase (NOS) activity, amino acid concentration in neutrophils, and expressions of NOS isoforms and p47(phox) by western blotting. Platelet aggregation was analyzed in the presence or absence of neutrophils. Oxidative status was measured through glutathione peroxidase, catalase activities, protein oxidation, lipid peroxidation, and DNA/RNA oxidation in serum. Basal NOS activity (pmol/10⁶ cells/min) was impaired in CRF patients on hemodialysis (0.33 ± 0.17) compared to controls (0.65 ± 0.12), whereas the expression of NOS isoforms remained unaltered. L-Arginine transport into neutrophils was similar in CRF patients on hemodialysis and controls. In addition, intracellular concentration of L-arginine was increased fourfold in the patient group. Systemic oxidative stress markers were not affected by CRF. On the other hand, NADPH oxidase subunit p47(phox) in neutrophils was overexpressed in CRF. In the presence of neutrophils, there was a reduction time-dependent in platelet aggregation in both groups with no difference between them. This data suggest that reduced basal generation of NO by neutrophils in CRF patients on hemodialysis occurs independently of L-arginine bioavailability and is able to suppress platelet activation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25524601     DOI: 10.1007/s11010-014-2302-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  The role of tetrahydrobiopterin in catalysis by nitric oxide synthase.

Authors:  Inaki Morao; Ganga Periyasamy; Ian H Hillier; John A Joule
Journal:  Chem Commun (Camb)       Date:  2006-07-13       Impact factor: 6.222

2.  ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.

Authors:  Guoquan Liu; Aaron T Place; Zhenlong Chen; Viktor M Brovkovych; Stephen M Vogel; William A Muller; Randal A Skidgel; Asrar B Malik; Richard D Minshall
Journal:  Blood       Date:  2012-07-17       Impact factor: 22.113

3.  Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo.

Authors:  Lefeng Wang; Ravi Taneja; Habib Moshref Razavi; Cedrin Law; Christopher Gillis; Sanjay Mehta
Journal:  Shock       Date:  2012-05       Impact factor: 3.454

Review 4.  Nitric oxide and the vascular endothelium.

Authors:  S Moncada; E A Higgs
Journal:  Handb Exp Pharmacol       Date:  2006

5.  Methylated arginines and nitric oxide in end-stage renal disease: impact of inflammation, oxidative stress and haemodialysis.

Authors:  Nadia Bouteldja; Richard J Woodman; Chris L Hewitson; Enric Domingo; Jeffrey A Barbara; Arduino A Mangoni
Journal:  Biomarkers       Date:  2013-05-14       Impact factor: 2.658

6.  The assessment of oxidative stress on patients with chronic renal failure at different stages and on dialysis patients receiving different hypertensive treatment.

Authors:  Servin Yeşil Günal; Bilal Ustündağ; Ali İhsan Günal
Journal:  Indian J Clin Biochem       Date:  2013-03-26

7.  Increased nitric oxide synthesis in uraemic platelets is dependent on L-arginine transport via system y(+)L.

Authors:  T M C Brunini; M M Yaqoob; L E Novaes Malagris; J C Ellory; G E Mann; A C Mendes Ribeiro
Journal:  Pflugers Arch       Date:  2002-11-09       Impact factor: 3.657

Review 8.  Nitric oxide, NAD(P)H oxidase, and atherosclerosis.

Authors:  Gregor Muller; Henning Morawietz
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

9.  Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature.

Authors:  Mokarram Hossain; Syed M Qadri; Lixin Liu
Journal:  J Inflamm (Lond)       Date:  2012-07-19       Impact factor: 4.981

10.  Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients.

Authors:  Hadja Fatima Tbahriti; Abbou Kaddous; Malika Bouchenak; Khedidja Mekki
Journal:  Biochem Res Int       Date:  2013-12-12
View more
  4 in total

1.  Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Deok Hwi Lim; Woo Jeong Ok; Gi Suk Nam; Min Ji Kim; Ho-Kyun Kwon; Jun-Hee Noh; Je-Young Lee; Hyun-Hong Kim; Jong-Lae Kim; Hwa-Jin Park
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

2.  Clinical Trial of the Effects of Coenzyme Q10 Supplementation on Biomarkers of Inflammation and Oxidative Stress in Diabetic Hemodialysis Patients.

Authors:  Melika Fallah; Gholamreza Askari; Alireza Soleimani; Awat Feizi; Zatollah Asemi
Journal:  Int J Prev Med       Date:  2019-01-15

3.  Local anaesthetics upregulate nitric oxide generation in cord blood and adult human neutrophils.

Authors:  Karolina I Kulinska; Maria Billert; Krzysztof Sawinski; Katarzyna Czerniak; Michał Gaca; Krzysztof Kusza; Krzysztof W Nowak; Maria Siemionow; Hanna Billert
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 4.  Role of Myeloperoxidase in Patients with Chronic Kidney Disease.

Authors:  Bojana Kisic; Dijana Miric; Ilija Dragojevic; Julijana Rasic; Ljiljana Popovic
Journal:  Oxid Med Cell Longev       Date:  2016-04-03       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.